Cho JY - Search Results

1

1-Benzylimidazole induces rat hepatic microsomal epoxide hydrolase with the elevation of its mRNA levels.

Cho JY, Nam SY, Kim SG. Cho JY, et al. Xenobiotica. 1995 Aug;25(8):791-8. doi: 10.3109/00498259509061894. Xenobiotica. 1995. PMID: 8779221

2

Differential expression of rat microsomal epoxide hydrolase gene by imidazole and triazole antimycotic agents.

Kim SG, Cho JY, Jung KH. Kim SG, et al. Among authors: cho jy. Drug Metab Dispos. 1995 Apr;23(4):460-4. Drug Metab Dispos. 1995. PMID: 7600912

3

Differential induction of hepatic microsomal epoxide hydrolase by alkyl sulphides and alkyl ethers in rat.

Cho JY, Kim SG. Cho JY, et al. Xenobiotica. 1997 Aug;27(8):759-67. doi: 10.1080/004982597240145. Xenobiotica. 1997. PMID: 9293614

4

Suppression of xenobiotic-metabolizing enzyme expression in rats by acriflavine, a protein kinase C inhibitor. Effects on epoxide hydrolase, glutathione S-transferases, and cytochromes p450.

Kim SG, Cho JY, Chung YS, Ahn ET, Lee KY, Han YB. Kim SG, et al. Among authors: cho jy. Drug Metab Dispos. 1998 Jan;26(1):66-72. Drug Metab Dispos. 1998. PMID: 9443855

5

Molecular mechanism for alkyl sulfide-modulated carbon tetrachloride-induced hepatotoxicity: the role of cytochrome P450 2E1, P450 2B and glutathione S-transferase expression.

Kim SG, Chung HC, Cho JY. Kim SG, et al. Among authors: cho jy. J Pharmacol Exp Ther. 1996 May;277(2):1058-66. J Pharmacol Exp Ther. 1996. PMID: 8627517

6

Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by acriflavine, an antimicrobial agent.

Choi SH, Cho JY, Chung YS, Hong E, Han Y, Kim SG. Choi SH, et al. Among authors: cho jy. Int J Immunopharmacol. 2000 Oct;22(10):775-87. doi: 10.1016/s0192-0561(00)00039-4. Int J Immunopharmacol. 2000. PMID: 10963850

7

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.

Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS. Cho JY, et al. Cancer. 1997 Mar 1;79(5):878-83. Cancer. 1997. PMID: 9041148

8

Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteers.

Jang IJ, Yu KS, Shon JH, Bae KS, Cho JY, Yi SY, Shin SG, Ryu KH, Cho YB, Kim DK, Yoo SE. Jang IJ, et al. Among authors: cho yb, cho jy. J Clin Pharmacol. 2000 Jul;40(7):752-61. doi: 10.1177/00912700022009512. J Clin Pharmacol. 2000. PMID: 10883417 Clinical Trial.

9

Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.

Park JO, Chung HC, Cho JY, Rha SY, You NC, Kim JH, Noh SH, Kim CB, Min JS, Kim BS, Roh JK. Park JO, et al. Among authors: cho jy. Am J Clin Oncol. 1997 Oct;20(5):484-9. doi: 10.1097/00000421-199710000-00010. Am J Clin Oncol. 1997. PMID: 9345333

10

Relationship between p53 overexpression and gastric cancer progression.

Kim JH, Uhm HD, Gong SJ, Shin DH, Choi JH, Lee HR, Noh SH, Kim BS, Cho JY, Rha SY, Yoo NC, Chung HC, Roh JK, Min JS, Lee KS, Kim BS. Kim JH, et al. Among authors: cho jy. Oncology. 1997 Mar-Apr;54(2):166-70. doi: 10.1159/000227682. Oncology. 1997. PMID: 9075790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,578 results

Search Page